Unleashing the Future: A Recap of Novonesis’s Q3 2024 Earnings Call

Novonesis A/S (OTCPK:NVZMF) Q3 2024 Earnings Conference Call November 7, 2024 3:00 AM ET Company Participants: Tobias Cornelius Björklund – Head, Investor Relations Ester Baiget – Chief Executive Officer Rainer Lehmann – Chief Financial Officer Jacob Paulsen – Executive Vice President, Food & Beverage Biosolutions Amy Byrick – Executive Vice President, Human Health Biosolutions Tina…

Read More

Entheon Announces Termination of Mentis AI Collaboration: What This Means for Entheon’s Future in Artificial Intelligence

Entheon Biomedical Corp. and Mentis AI: A Terminated Agreement On March 14, 2025, Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (“Entheon”), a biotech company specializing in the development of psychedelic medicines, announced that 1000141080 Ontario Ltd. (“Mentis AI”), the company it had planned to acquire, has terminated the letter of intent (LOI). This…

Read More

Attention TSLA Investors: Take Action Now to Lead Class Action Lawsuit and Recover Substantial Losses – Announcement by Robbins Geller Rudman & Dowd LLP

FRIDAY TSLA INVESTOR DEADLINE: Opportunity for Tesla, Inc. Investors Take Action Before April 28th Investors and individuals who have purchased or acquired Tesla, Inc. (NASDAQ: TSLA) common stock between February 19, 2019 to February 17, 2023 should take note – the deadline for seeking appointment as lead plaintiff in the Class Period is approaching fast….

Read More

Axis Y Indonesia Launches Anti-Counterfeit Campaign: #AxisYIsFinallyBack

A Vegan-Certified Korean Skincare Brand Makes a Comeback in Indonesia In an effort to combat counterfeit beauty products in Indonesia, AXIS-Y, a vegan-certified Korean skincare brand, is launching a new campaign called #AXISYisfinallyback. This campaign aims to address the growing concerns over fake AXIS-Y products in the Indonesian market and re-establish the brand’s presence in…

Read More

“MediWound Launches Phase III Trial for Venous Leg Ulcers, Aiming for 2025 Release”

MediWound: Advancing Wound Care with Innovative Treatments Phase III Trial for Venous Leg Ulcer Treatment MediWound, a leading Israeli developer of innovative products for treating burns and wounds through non-surgical tissue repair, has recently announced the commencement of a Phase III clinical trial for its revolutionary treatment for venous leg ulcers. This significant development marks…

Read More

Bitcoin ETF: The Heart-Wrenching Rollercoaster Ride Continues – Understanding the Latest Demand Dilemma for Cryptocurrency Investors

Bitcoin ETFs Witness Another Round of Outflows: What Does It Mean for Investors and the World? The cryptocurrency market has been experiencing a bearish trend recently, with Bitcoin, the largest and most popular digital asset, leading the decline. This trend has had a ripple effect on Bitcoin Exchange-Traded Funds (ETFs) listed in the US, which…

Read More